Utilization and effectiveness of extended-duration thromboprophylaxis after high-risk abdominopelvic cancer surgery.

Authors

null

Jason Dennis Wright

Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital, New York, NY

Jason Dennis Wright, Ling Chen, Soledad Jorge, William M. Burke, Ana Tergas, June Hou, Jim Hu, Alfred I. Neugut, Cande Ananth, Dawn L. Hershman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A: Practice of Quality and Cost, Value, and Policy in Quality

Track

Cost, Value, and Policy in Quality,Practice of Quality,Science of Quality

Sub Track

Involving Patients in Quality Care

Citation

J Clin Oncol 34, 2016 (suppl 7S; abstr 62)

DOI

10.1200/jco.2016.34.7_suppl.62

Abstract #

62

Poster Bd #

F1

Abstract Disclosures

Similar Posters

Poster

2021 ASCO Quality Care Symposium

Rate of venous thromboembolism in gynecologic patients on an ERAS pathway.

Rate of venous thromboembolism in gynecologic patients on an ERAS pathway.

First Author: Jolyn Sharpe Taylor

Poster

2016 ASCO Annual Meeting

Validation of a thrombosis risk assessment model in patients with newly diagnosed multiple myeloma.

Validation of a thrombosis risk assessment model in patients with newly diagnosed multiple myeloma.

First Author: Brea Lipe

Poster

2023 ASCO Annual Meeting

Venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer.

Venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer.

First Author: Hannah Dysinger McLaughlin

Poster

2022 ASCO Annual Meeting

Hysterectomy as a risk-reducing procedure in <em>BRCA1</em> and <em>BRCA2</em> women.

Hysterectomy as a risk-reducing procedure in BRCA1 and BRCA2 women.

First Author: Ana Teresa Pina